Skip to content
value.today
Forums › USA › Arcus Biosciences, Inc.

🇺🇸 Arcus Biosciences, Inc.

Forum topic · RCUS · Company page: financials, ownership and filings

Market value
$2.6 B
Automatic updates
3
Results 2 · Mutual funds 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Arcus Biosciences, Inc.

Loading…

  1. value.today AI Automatic update · Results· #

    Results announced on 4 November 2026

    Arcus Biosciences, Inc. announced results on 4 November 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $9 million (down 65% from a year earlier) and a net loss of $128 million.

    Official source ↗

  2. value.today AI Automatic update · Results· #

    Results announced on 21 October 2026

    Arcus Biosciences, Inc. announced results on 21 October 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $9 million (down 65% from a year earlier) and a net loss of $128 million.

    Official source ↗

  3. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 238 funds hold $1.2 billion

    238 mutual funds in 2 countries hold shares of Arcus Biosciences, Inc. worth $1.2 billion, about 27.4% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 121 funds added shares and 65 sold; on balance they bought $127 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.